项目作者: EmanuelGoncalves

项目描述 :
Integration of pharmacological and drop-out CRISPR-Cas9 screens
高级语言: Jupyter Notebook
项目地址: git://github.com/EmanuelGoncalves/dtrace.git
创建时间: 2018-03-08T10:02:39Z
项目社区:https://github.com/EmanuelGoncalves/dtrace

开源协议:BSD 3-Clause "New" or "Revised" License

下载


robust_scatter_Dabrafenib_BRAF_BRAF_mut_1648608626500.pdf
robust_scatter_GDC-0879_BRAF_BRAF_mut_1648608626750.pdf
robust_scatter_Linifanib_FLT3_FLT3_mut_1648608627085.pdf
robust_scatter_MCL1_1284_MCL1_EZH2_mut_1648608627335.pdf
robust_scatter_Nutlin-3a (-)_MDM2_TP53_mut_1648608627590.pdf
robust_scatter_Olaparib_FLI1_EWSR1.FLI1_mut_1648608627884.pdf
robust_scatter_Taselisib_PIK3CA_PIK3CA_mut_1648608628155.pdf
robust_scatter_gexp_AZD5582_MAP3K7_TNF_1648608628440.pdf
robust_scatter_gexp_EGFRM_5104_ERBB2_ERBB2_1648608628598.pdf
robust_scatter_gexp_IAP_5620_MAP3K7_TNF_1648608628813.pdf
robust_scatter_gexp_Linsitinib_IGF1R_IGF1R_1648608629124.pdf
robust_scatter_gexp_MCL1_1284_MCL1_BCL2L1_1648608629390.pdf
robust_scatter_gexp_Nutlin-3a (-)_MDM2_BAX_1648608629571.pdf
robust_scatter_gexp_Venetoclax_BCL2_BCL2_1648608629984.pdf
robust_scatter_gexp_Venetoclax_BCL2_CDC42BPA_1648608630301.pdf
robust_scatter_gexp_alternative_TNF_1648608630572.pdf
robust_scatter_gexp_crispr_STAG2_STAG1_STAG2_mut_1648608631021.pdf
robust_signif_association_barplot_1648608631433.pdf
robust_signif_association_barplot_ppi_1648608631927.pdf
robust_top_associations_1648608632233.pdf
robust_top_associations_gexp_1648608632493.pdf
target_benchmark_association_countplot_1648608632979.pdf
target_benchmark_association_signif_barplot_1648608633397.pdf
target_benchmark_association_signif_countplot_1648608633691.pdf
target_benchmark_association_signif_piechart_1648608633973.pdf
target_benchmark_associations_barplot_1648608634445.pdf
target_benchmark_associations_barplot_AKT_1648608634838.pdf
target_benchmark_associations_barplot_BRAF_1648608635123.pdf
target_benchmark_associations_barplot_EGFR_1648608635517.pdf
target_benchmark_associations_barplot_ERBB2_1648608635792.pdf
target_benchmark_associations_barplot_ERBB2;EGFR_1648608635850.pdf
target_benchmark_associations_barplot_FGFR1_1648608636041.pdf
target_benchmark_associations_barplot_IGF1R_1648608636301.pdf
target_benchmark_associations_barplot_JAK_1648608636672.pdf
target_benchmark_associations_barplot_MCL1 and BCL2_1648608636963.pdf
target_benchmark_associations_barplot_MDM2_1648608637217.pdf
target_benchmark_associations_barplot_MET_1648608637579.pdf
target_benchmark_associations_barplot_NTRK_1648608638214.pdf
target_benchmark_associations_barplot_PIK3C_1648608638538.pdf
target_benchmark_associations_barplot_SLC16A1_1648608639129.pdf
target_benchmark_associations_barplot_cIAP_1648608639474.pdf
target_benchmark_beta_histogram_1648608640111.pdf
target_benchmark_chembl_boxplot_1648608640478.pdf
target_benchmark_clustermap_betas_crispr_legend_1648608641317.pdf
target_benchmark_drug_notarget_Olaparib_1648608641669.pdf
target_benchmark_drug_notarget_Talazoparib_1648608642270.pdf
target_benchmark_drug_signif_crispr_std_boxplot_1648608642619.pdf
target_benchmark_drug_signif_drug_std_boxplot_1648608643029.pdf
target_benchmark_drug_signif_enrichment_barplot_1648608643336.pdf
target_benchmark_drugs_group_barplot_1648608643767.pdf
target_benchmark_kinobeads_1648608644344.pdf
target_benchmark_ppi_distance_crispr_1648608644809.pdf
target_benchmark_ppi_distance_crispr_countplot_bkg_1648608645140.pdf
target_benchmark_ppi_distance_gexp_1648608645505.pdf
target_benchmark_ppi_distance_gexp_countplot_bkg_1648608645799.pdf
target_benchmark_pval_histogram_1648608646374.pdf
target_benchmark_signif_fdr_scatter_1648608646695.pdf
target_benchmark_signif_genomic_heatmap_1648608646921.pdf
target_benchmark_signif_scatter_maxconcentration_1648608647400.pdf
target_benchmark_signif_scatter_maxconcentration_below_%_1648608647748.pdf
target_benchmark_signif_scatter_maxconcentration_min_resp_1648608648111.pdf
target_benchmark_significant_by_screen_1648608648422.pdf
target_benchmark_top_associations_barplot_AZD5582_1648608648736.pdf
target_benchmark_top_associations_barplot_AZD6738_1648608649056.pdf
target_benchmark_top_associations_barplot_AZD8186_1648608649723.pdf
target_benchmark_top_associations_barplot_Alpelisib_1648608649893.pdf
target_benchmark_top_associations_barplot_Buparlisib_1648608650111.pdf
target_benchmark_top_associations_barplot_Cetuximab_1648608650445.pdf
target_benchmark_top_associations_barplot_IAP_5620_1648608650625.pdf
target_benchmark_top_associations_barplot_Ibrutinib_1648608650684.pdf
target_benchmark_top_associations_barplot_Omipalisib_1648608651021.pdf
target_benchmark_top_associations_barplot_VE-822_1648608651234.pdf
target_benchmark_top_associations_barplot_VE821_1648608651737.pdf
target_benchmark_volcano_1648608652168.pdf
hit_target_drugs_corr_MARCH5_1648608620642.pdf
hit_target_drugs_corr_MCL1_1648608621014.pdf
hit_topbarplot_1648608621280.pdf
preliminary_crispr_pca_growth_corrplot_1648608621633.pdf
preliminary_crispr_pca_growth_pcs_barplot_1648608621936.pdf
preliminary_crispr_pca_pairplot_cancertype_1648608622536.pdf
preliminary_crispr_pca_pairplot_samples_1648608622912.pdf
preliminary_drug_histogram_drug_1648608623331.pdf
preliminary_drug_histogram_samples_1648608623646.pdf
preliminary_drug_pca_growth_corrplot_1648608624028.pdf
preliminary_drug_pca_growth_corrplot_histogram_1648608624283.pdf
preliminary_drug_pca_growth_corrplot_top_1648608624602.pdf
preliminary_drug_pca_growth_pcs_barplot_1648608624651.pdf
preliminary_drug_pca_pairplot_1648608624934.pdf
preliminary_drug_pca_pairplot_cancertype_1648608625190.pdf
preliminary_drug_pca_pairplot_samples_1648608625328.pdf
robust_genomic_boxplot_STAG2_mut_1648608625523.pdf
robust_mobems_countplot_1648608625834.pdf
robust_scatter_CP-724714_ERBB2_gain.cnaPANCAN301..CDK12.ERBB2.MED24._1648608626239.pdf
drug_crispr_icon_1648608552842.pdf
association_drug_gexp_scatter_Afatinib_ERBB2_1648608601530.pdf
association_drug_gexp_scatter_Nutlin-3a (-)_MDM2_1648608601821.pdf
association_drug_gexp_scatter_Poziotinib_ERBB2_1648608601990.pdf
association_drug_gexp_scatter_WEHI-539_BCL2L1_1648608602209.pdf
association_drug_scatter_ASLAN002_MET_1648608602648.pdf
association_drug_scatter_AZD4547_FGFR1_1648608602980.pdf